(19)
(11) EP 4 823 754 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828686.6

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
B01L 3/00(2006.01)
G01N 21/00(2006.01)
B01L 7/00(2006.01)
(52) Cooperative Patent Classification (CPC):
B01L 3/502; B01L 2200/16; B01L 2300/0672; B01L 2400/049; B01L 2300/044; B01L 7/52; B01L 3/527; B01L 3/523; B01L 3/5635; G01N 2021/6419; G01N 2021/6421; G01N 2021/6482
(86) International application number:
PCT/US2024/059511
(87) International publication number:
WO 2025/128663 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 12.12.2023 US 202363609013 P

(71) Applicants:
  • Revvity Health Sciences, Inc.
    Waltham, MA 02451 (US)
  • Revvity Cellular Technologies GmbH
    22525 Hamburg (DE)

(72) Inventors:
  • KRAUS, Morey Richard
    Waltham, Massachusetts 02451 (US)
  • MÜLLER, Jürgen Rolf
    22525 Hamburg (DE)
  • JOSEPH, Richard Abraham
    Waltham, Massachusetts 02451 (US)

(74) Representative: Appleyard Lees IP LLP 
G Mill Dean Clough Industrial Park
Halifax HX3 5AH
Halifax HX3 5AH (GB)

   


(54) SYSTEMS AND METHODS FOR TESTING FOR INFECTIOUS DISEASE